{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:14:06Z","timestamp":1790878446655,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004913","name":"University of Palermo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR-M4C2"],"award-info":[{"award-number":["PNRR-M4C2"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jmgm.2025.109100","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:48:28Z","timestamp":1748774908000},"page":"109100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combinatorial chemistry-driven In silico design and computational evaluation of covalent peptidomimetic SARS-CoV-2 main protease inhibitors via structure-based virtual screening and multivariate analysis"],"prefix":"10.1016","volume":"140","author":[{"given":"Alessia","family":"Bono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"La Monica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Alamia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mingoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109100_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105948","article-title":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence","volume":"55","author":"Wang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jmgm.2025.109100_bib2","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"10.1016\/j.jmgm.2025.109100_bib3","first-page":"1","article-title":"SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations","author":"Krishnamoorthy","year":"2020","journal-title":"Virusdisease"},{"key":"10.1016\/j.jmgm.2025.109100_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14760584.2021.1903879","article-title":"Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies","volume":"20","author":"Bian","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmgm.2025.109100_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040607","article-title":"SARS-CoV-2 mpro: a potential target for peptidomimetics and small-molecule inhibitors","volume":"11","author":"Citarella","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2025.109100_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.csbj.2020.12.035","article-title":"Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2","volume":"19","author":"Zhu","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jmgm.2025.109100_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41421-020-0169-8","article-title":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.jmgm.2025.109100_bib8","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1503\/cmaj.200528","article-title":"Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection","volume":"192","author":"Juurlink","year":"2020","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.jmgm.2025.109100_bib9","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS-CoV-2: recent reports on antiviral therapies based on lopinavir\/ritonavir, darunavir\/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus","volume":"27","author":"Costanzo","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib10","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1021\/acs.jpcb.0c07312","article-title":"Remdesivir strongly binds to both RNA-dependent RNA polymerase and main protease of SARS-CoV-2: evidence from molecular simulations","volume":"124","author":"Nguyen","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2025.109100_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2025.109100_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100849","article-title":"Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial","volume":"35","author":"Gunst","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jmgm.2025.109100_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105998","article-title":"Arbidol: a potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein","volume":"56","author":"Vankadari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jmgm.2025.109100_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: the reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"Encephale"},{"key":"10.1016\/j.jmgm.2025.109100_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106274","article-title":"Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine","volume":"57","author":"Plaze","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jmgm.2025.109100_bib16","series-title":"Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent against SARS-CoV-2","year":"2021"},{"key":"10.1016\/j.jmgm.2025.109100_bib17","series-title":"Pfizer Unveils its Oral SARS-CoV-2 Inhibitor","author":"Halford","year":"2021"},{"key":"10.1016\/j.jmgm.2025.109100_bib18","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109100_bib19","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1074\/jbc.M411122200","article-title":"Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp","volume":"280","author":"Mori","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/jpet.120.000123","article-title":"Drug discovery strategies for SARS-CoV-2","volume":"375","author":"Shyr","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jmgm.2025.109100_bib21","first-page":"210","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology (New York, N. Y.)"},{"key":"10.1016\/j.jmgm.2025.109100_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2011.02.003","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB\/c mouse model by stinging nettle lectin, Urtica dioica agglutinin","volume":"90","author":"Kumaki","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2025.109100_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-020-00318-0","article-title":"Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jmgm.2025.109100_bib24","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1038\/s41467-020-18387-8","article-title":"Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain","volume":"11","author":"Chi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109100_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2025.109100_bib26","article-title":"Potent neutralization of SARS-CoV-2 in vitro and in an animal model by a human monoclonal antibody","author":"Li","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmgm.2025.109100_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109100_bib28","first-page":"1274","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.jmgm.2025.109100_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies","volume":"181","author":"Wrapp","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2025.109100_bib30","first-page":"643","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.jmgm.2025.109100_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104820","article-title":"Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2","volume":"179","author":"Tai","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2025.109100_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.jmgm.2025.109100_bib33","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2025.109100_bib34","series-title":"Use of Siltuximab in Patients with COVID-19 Pneumonia Requiring Ventilatory Support","author":"Gritti","year":"2020"},{"key":"10.1016\/j.jmgm.2025.109100_bib35","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3389\/fimmu.2020.01844","article-title":"Immunomodulatory drugs in the management of SARS-CoV-2","volume":"11","author":"Burrage","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmgm.2025.109100_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jmgm.2025.109100_bib37","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/acs.jcim.1c00449","article-title":"Dynamic profiling of \u03b2-coronavirus 3CL mpro protease ligand-binding sites","volume":"61","author":"Cho","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109100_bib38","first-page":"409","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.jmgm.2025.109100_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109100_bib40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1039\/D0SC06195F","article-title":"Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM\/MM simulations and design of new derivatives with tunable chemical reactivity","volume":"12","author":"Arafet","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmgm.2025.109100_bib41","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1021\/acscatal.0c03420","article-title":"Unraveling the SARS-CoV-2 main protease mechanism using multiscale methods","volume":"10","author":"Ramos-Guzm\u00e1n","year":"2020","journal-title":"ACS Catal."},{"key":"10.1016\/j.jmgm.2025.109100_bib42","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1039\/D0SC02823A","article-title":"Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M","volume":"11","author":"\u015awiderek","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmgm.2025.109100_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116386","article-title":"Recent progress in covalent warheads for in vivo targeting of endogenous proteins","volume":"47","author":"Shindo","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114636","article-title":"Development and application of novel electrophilic warheads in target identification and drug discovery","volume":"190","author":"Liu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109100_bib45","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/acs.jmedchem.8b01153","article-title":"Emerging and Re-emerging warheads for targeted covalent inhibitors: applications in medicinal chemistry and chemical biology","volume":"62","author":"Gehringer","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib46","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2025.109100_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbrc.2005.02.061","article-title":"The substrate specificity of SARS coronavirus 3C-like proteinase","volume":"329","author":"Fan","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2025.109100_bib48","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c01005","article-title":"Targeting SARS-CoV-2 main protease for treatment of COVID-19: covalent inhibitors structure-activity relationship insights and evolution perspectives","author":"La Monica","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jmgm.2025.109100_bib50","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.jmgm.2025.109100_bib51","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/bioinformatics\/btz783","article-title":"DRUDIT: web-based DRUgs DIscovery Tools to design small molecules as modulators of biological targets","volume":"36","author":"Lauria","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2025.109100_bib52","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/acsomega.2c07346","article-title":"Cheminformatic analysis and machine learning modeling to investigate androgen receptor antagonists to combat prostate cancer","volume":"8","author":"Yu","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jmgm.2025.109100_bib53","doi-asserted-by":"crossref","first-page":"43500","DOI":"10.1021\/acsomega.3c03225","article-title":"Machine learning approaches to investigate the structure-activity relationship of angiotensin-converting enzyme inhibitors","volume":"8","author":"Yu","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jmgm.2025.109100_bib54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/1062936X.2021.1955414","volume":"32","author":"Das","year":"2021","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2025.109100_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107956","article-title":"Computational analysis of the interactions between Ebselen and derivatives with the active site of the main protease from SARS-CoV-2","volume":"107","author":"Rieder","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202100028","article-title":"In silico studies on the interaction between mpro and PLpro from SARS-CoV-2 and ebselen, its metabolites and derivatives","volume":"40","author":"Nogara","year":"2021","journal-title":"Mol Inform"},{"key":"10.1016\/j.jmgm.2025.109100_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/app11146291","article-title":"Mechanistic insight into sars\u2010cov\u20102 mpro inhibition by organoselenides: the ebselen case study","volume":"11","author":"Madabeni","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jmgm.2025.109100_bib58","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/ci400131y","article-title":"Effect of halogen substitutions on dUMP to stability of thymidylate synthase\/dUMP\/mTHF ternary complex using molecular dynamics simulation","volume":"53","author":"Kaiyawet","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109100_bib59","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1021\/acs.molpharmaceut.6b00302","article-title":"Identification of covalent binding sites targeting cysteines based on computational approaches","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jmgm.2025.109100_bib60","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109100_bib61","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/ci500175r","article-title":"Structure-based virtual screening approach for discovery of covalently bound ligands","volume":"54","author":"Toledo Warshaviak","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109100_bib62","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109100_bib63","article-title":"Evaluation of free online ADMET tools for academic or small biotech environments","volume":"28","author":"Dulsat","year":"2023","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.jmgm.2025.109100_bib64","series-title":"Schr\u00f6dinger Release 2017-1 : QikProp","year":"2017"},{"key":"10.1016\/j.jmgm.2025.109100_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2025.109100_bib66","series-title":"Schr\u00f6dinger Release 2017-2, LigPrep","year":"2017"},{"key":"10.1016\/j.jmgm.2025.109100_bib67","series-title":"Schr\u00f6dinger Release 2017-2, Schr\u00f6dinger Suite 2017-2 Protein Preparation Wizard","year":"2017"},{"key":"10.1016\/j.jmgm.2025.109100_bib68","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109100_bib69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109100_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2025.109100_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an induced fit receptor structure in virtual screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2025.109100_bib73","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:35:02Z","timestamp":1764732902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"alternative-id":["S1093326325001603"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109100","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial chemistry-driven In silico design and computational evaluation of covalent peptidomimetic SARS-CoV-2 main protease inhibitors via structure-based virtual screening and multivariate analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109100"}}